Stocks-BRNS-Barinthus Biotherapeutics PLC

Barinthus Biotherapeutics PLC BRNS

‎$‎0.60000.06(11.09%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Barinthus Biotherapeutics PLC
Today

Create an eToro account to buy BRNS stock on a secure, user-friendly, multi-asset trading platform.

Barinthus Biotherapeutics PLC BRNS

Buy BRNS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

EIFF.PA

Societe de la Tour Eiffel SA

Eastman Kodak Company

Alerion Clean Power S.p.A

‎€‎21.75

+6.36%

SBAC

SBA Communications Corporation

MAX

*Past performance is not an indication of future results

Jump to:

About BRNS >
How to Buy? >
Top Guides >

The Barinthus Biotherapeutics PLC share price is stable this week.

The Barinthus Biotherapeutics PLC price today is ‎$‎0.6000, a ‎11.09‎% change in the last 24 hours and ‎0‎% in the past week. Barinthus Biotherapeutics PLC price changed by ‎0‎% in the past year.

BRNS Key Metrics

Market Cap

Day’s Range

‎$‎0.53 - ‎$‎0.561

52W Range

‎$‎0.5 - ‎$‎0.7501

Average Volume (3M)

Price-Earnings Ratio

Revenue

Dividend (Yield)

Prev Close

‎$‎0.6

EPS

Beta

How can I buy Barinthus Biotherapeutics PLC stocks?

To purchase Barinthus Biotherapeutics PLC:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Barinthus Biotherapeutics PLC (BRNS) page and place an order to buy Barinthus Biotherapeutics PLC.

Buy BRNS

Looking for more information? Check out our guide on Academy.

What Is Barinthus Biotherapeutics PLC?

Barinthus Biotherapeutics PLC is a global, UK-based clinical-stage biotechnology company developing novel immunotherapies which are designed to treat immunology and inflammatory indications by guiding T cells to overcome autoimmunity and inflammatory diseases.

Operating within the healthcare sector, Barinthus Biotherapeutics PLC arose from the merger of Oxford University spinout Vaccitech, Plc and National National Institutes of Health (NIH) and Johns Hopkins University spinout, Avidea Technologies Inc in 2021 with the aim of joining two leading immunotherapeutic companies with complementary technologies and expertise

Keep up to date on the latest share price changes by adding BRNS stock to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

William Enright

Employees

Founded

2021

Didcot, Oxfordshire, GB

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Barinthus Biotherapeutics PLC
Today

Create an eToro account to buy BRNS stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Barinthus Biotherapeutics PLC stock?

The current price of BRNS is ‎$‎0.6000.

What are analysts’ forecasts for Barinthus Biotherapeutics PLC?

Analysts offer forecasts for Barinthus Biotherapeutics PLC based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Barinthus Biotherapeutics PLC?

The market capitalisation of Barinthus Biotherapeutics PLC is (The data is unavailable right now)

Daily Movers

Explore the biggest stocks movers on the market.